Literature DB >> 16776810

Persistence with bisphosphonate therapy in older people.

Magda Melo, Feng Qiu, Kathy Sykora, David Juurlink, Andreas Laupacis, Muhammad Mamdani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16776810     DOI： 10.1111/j.1532-5415.2006.00758.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  9 in total

1.  Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations.

Authors:  Milica Nikitovic; Daniel H Solomon; Suzanne M Cadarette
Journal:  Ther Adv Chronic Dis       Date:  2010-11-01       Impact factor: 5.091

Review 2.  Measuring and improving adherence to osteoporosis pharmacotherapy.

Authors:  Suzanne M Cadarette; Andrea M Burden
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

3.  Comparative adherence to oxybutynin or tolterodine among older patients.

Authors:  Tara Gomes; David N Juurlink; Muhammad M Mamdani
Journal:  Eur J Clin Pharmacol       Date:  2011-06-28       Impact factor: 2.953

4.  Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis.

Authors:  Dirk Mueller; Eva Weyler; Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Treatment pattern in postmenopausal women with osteoporosis: a population-based cohort study in South Korea.

Authors:  Ju Hwan Kim; Han Eol Jeong; Yeon-Hee Baek; Sun Wook Cho; Hyuna Lim; Ju-Young Shin
Journal:  J Bone Miner Metab       Date:  2021-08-23       Impact factor: 2.626

6.  Decision to take osteoporosis medication in patients who have had a fracture and are 'high' risk for future fracture: a qualitative study.

Authors:  Joanna E M Sale; Monique A Gignac; Gillian Hawker; Lucy Frankel; Dorcas Beaton; Earl Bogoch; Victoria Elliot-Gibson
Journal:  BMC Musculoskelet Disord       Date:  2011-05-09       Impact factor: 2.362

7.  Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada.

Authors:  A M Burden; J M Paterson; D H Solomon; M Mamdani; D N Juurlink; S M Cadarette
Journal:  Osteoporos Int       Date:  2011-05-21       Impact factor: 4.507

8.  Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.

Authors:  L A Wozniak; J A Johnson; F A McAlister; L A Beaupre; D Bellerose; B H Rowe; S R Majumdar
Journal:  Osteoporos Int       Date:  2016-07-16       Impact factor: 4.507

9.  Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: An interrupted time series analysis.

Authors:  Dorcas E Beaton; Muhammad Mamdani; Hong Zheng; Susan Jaglal; Suzanne M Cadarette; Earl R Bogoch; Joanna E M Sale; Rebeka Sujic; Ravi Jain
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.